Ayuvis Research Inc

Overview

COVID-19- and SARS-induced ARDS AyuVis research is developing a new class of drugs to treat complicated respiratory infections such as BPD and PAP with promising preclinical data. Both of these indications are associated with ARDS, which can be induced by the Corona virus.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412